Abiopharma

🔍 HELMERICH HANS (Executive)

Company: Helmerich & Payne, Inc. (HP)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Sold 25,000 shares of Common Stock at $43.9 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 471,735.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 65,000 shares of Common Stock at $43.9 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,150,915.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,470 shares of Common Stock at $43.9 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 20,000.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: H | shares_owned_after: 138,009.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: H | nature_of_ownership: By LLC | shares_owned_after: 44,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: H | nature_of_ownership: Children\'s Trust | shares_owned_after: 67,100.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: H | nature_of_ownership: 401(k) Account | shares_owned_after: 20,930.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: H | nature_of_ownership: Peggy Helmerich Trust | shares_owned_after: 40,000.00

Footnotes:

• F1: The price in this column is the weighted average sale price for the transactions reported. The prices ranged from $43.83 to $44.03. The reporting person will provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold by the reporting person at each separate price.